Celldex Therapeutics, Inc.CLDXNASDAQ
LOADING
|||
ROE: Strong Returns
Trending higher, above historical average, slight contraction.
Left:
||||
Return on equity
Latest
-21.13%
↑ 52% above average
Average (9y)
-44.15%
Historical baseline
Range
High:-16.81%
Low:-121.86%
CAGR
-7.8%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | -21.13% | +35.9% |
| 2023 | -32.95% | +4.3% |
| 2022 | -34.43% | -104.9% |
| 2021 | -16.81% | +41.1% |
| 2020 | -28.55% | +47.2% |
| 2019 | -54.11% | +55.6% |
| 2018 | -121.86% | -209.6% |
| 2017 | -39.36% | +18.7% |
| 2016 | -48.42% | -10.4% |
| 2015 | -43.85% | - |